Recalibrating the risks and benefits of lithium therapy

Michael Berk; Stephanie Cowdery; Lana J. Williams; Gin S Malhi

doi:10.1192/bjp.bp.116.193789

Recalibrating the risks and benefits of lithium therapy

Michael Berk, Stephanie Cowdery, Lana J. Williams, Gin S Malhi

Research output: Contribution to journal › Editorial › Research › peer-review

14 Citations (Scopus)

Abstract

Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	The British Journal of Psychiatry
Volume	211
Issue number	1
DOIs	https://doi.org/10.1192/bjp.bp.116.193789
Publication status	Published - 1 Jul 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1192/bjp.bp.116.193789

106853272-oaFinal published version, 186 KB

Cite this

@article{a1ddc6b015a84eacba6978603ad64194,

title = "Recalibrating the risks and benefits of lithium therapy",

abstract = "Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.",

author = "Michael Berk and Stephanie Cowdery and Williams, {Lana J.} and Malhi, {Gin S}",

year = "2017",

month = jul,

day = "1",

doi = "10.1192/bjp.bp.116.193789",

language = "English",

volume = "211",

pages = "1--2",

journal = "The British Journal of Psychiatry",

issn = "0007-1250",

publisher = "Cambridge University Press",

number = "1",

}

TY - JOUR

T1 - Recalibrating the risks and benefits of lithium therapy

AU - Berk, Michael

AU - Cowdery, Stephanie

AU - Williams, Lana J.

AU - Malhi, Gin S

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

AB - Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

UR - http://www.scopus.com/inward/record.url?scp=85021796063&partnerID=8YFLogxK

U2 - 10.1192/bjp.bp.116.193789

DO - 10.1192/bjp.bp.116.193789

M3 - Editorial

AN - SCOPUS:85021796063

SN - 0007-1250

VL - 211

SP - 1

EP - 2

JO - The British Journal of Psychiatry

JF - The British Journal of Psychiatry

IS - 1

ER -

Recalibrating the risks and benefits of lithium therapy

Abstract

UN SDGs

Access to Document

Other files and links

Cite this